In connection with the treatment of cell-related abnormalities with therapies heretofore having unavoidable adverse side effects, using a known high frequency electromagnetic therapy used heretofore for blood-related abnormalities having no significant adverse side effects, with the unobvious result that as a substitute therapy for the cell-related abnormalities there are also no adverse side effects characteristic of the use thereof for blood-related abnormalities.